Sign inJoin waitlistJoin the waitlist

Iftikhar Hanif

Vice Chief and Medical Director, Clinical Research Pediatric Hematology-Oncology Program · Memorial Healthcare System, Hollywood, Florida

Credentials: · ·

History

Clinical Research Pediatric Hematology-Oncology Program · Memorial Healthcare System, Hollywood, Florida
Present

St Jude Children's Research Hospital
1991–1992
Pediatric Cardiology
Children's Hospital of Michigan
1984–1987
Pediatrics
1984–1987
Dow Medical College
1980–1984

Research

Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study
The Lancet Haematology · 2020 · 91 citations
Avascular femoral head necrosis in pediatric cancer patients
Case report · Medical and Pediatric Oncology · 1993 · First of 3 authors · 44 citations
Cytologic diagnosis of respiratory syncytial virus infection in a bronchoalveolar lavage specimen from a bone marrow transplant recipient
Case report · American Journal of Clinical Pathology · 1993 · Last of 6 authors · 15 citations

Malcolm Brenner
2 papers
Akiko Shimamura
1 paper
Ashley Galvin
1 paper
BA
Blanche Alter
1 paper
Bradford Siegele
1 paper
Carlos Bueso-Ramos
1 paper
Ching-Hon Pui
1 paper
Courtney DiNardo
1 paper
David Parham
1 paper
EF
Elissa Furutani
1 paper
Etan Orgel
1 paper
FB
Farid Boulad
1 paper

Clinical trials

Quality of End-of-Life Care for Children With Cancer
Site PI · Recruiting
Children's Oncology Group
2026–2031
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2026–2031
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030